VEGFA and neoplasm: This upregulation of the proangiogenic factors and their interconnected signaling pathways not only contributes to increased vascular permeability, tumor growth and angiogenesis, but also contributes to the suboptimal response to VEGF/VEGFR targeting therapy [120, 156].